Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Big Is The Short-Acting Insulin Market Today And What Is Its Future Size?

There has been a consistent increase in the market size of short-acting insulin in past years. It is expected to escalate from its $11 billion value in 2024 to approximately $11.54 billion by 2025, exhibiting a compound annual growth rate (CAGR) of 4.8%. Factors contributing to this incline during the historical period include a rise in type 1 diabetes sufferers, an aging population, an uptick in funding for research and development, a surge in reported diagnosis, and accelerated urbanization.

In the coming years, the market size of short-acting insulin is predicted to experience robust growth, potentially escalating to “$14.14 billion in 2029, with a compound annual growth rate (CAGR) of 5.2%. The projected growth within this period can be associated with increased governmental initiatives and support, swift advancements in production techniques, a greater adoption of insulin therapy, and the emergence of personalized medicine. The forecast period is expected to witness major trends such as improvement in insulin delivery devices and technologies, the introduction of innovative fast-acting insulin analogs, the creation of biosimilars, a move towards patient-focused care, and advancements in drug formulation.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21287&type=smp

What Are The Primary Factors Supporting The Short-Acting Insulin Market Expansion?

The heightened occurrence of type 1 diabetes is likely to drive the expansion of the short-acting insulin market. This autoimmune condition, in which insulin-producing cells are destroyed by the body, necessitates lifelong insulin treatment. Factors such as genetics, environmental triggers, and a rise in autoimmune disorders are behind the growing prevalence of Type 1 diabetes. Short-acting insulin assists in the management of type 1 diabetes by enabling prompt blood sugar regulation and emulating the natural insulin reaction. Diabetes Australia, a body dedicated to raising diabetes awareness, stated that in 2022, around 134,000 Australians were living with Type 1 diabetes. This number increased to 135,423 in 2023. Consequently, the growing occurrence of type 1 diabetes is propelling the expansion of the short-acting insulin market.

Which Sub-Segments Are Driving Growth Within The Short-Acting Insulin Market?

The short-acting insulin market covered in this report is segmented –

1) By Formulation: Regular Insulin, Rapid-Acting Insulin

2) By Dosage Form: Vials, Pre-filled Pens, Cartridges

3) By Route Of Administration: Subcutaneous, Intravenous

4) By Patient Type: Type 1 Diabetes, Type 2 Diabetes

5) By Distribution Channel: Pharmacies, Hospital Pharmacies, Online Pharmacies

Subsegments:

1) By Regular Insulin: Human Regular Insulin, Animal-Derived Regular Insulin, Other Regular Insulin

2) By Rapid-Acting Insulin: Insulin Lispro, Insulin Aspart, Insulin Glulisine

What Future-Focused Trends Are Anticipated In The Short-Acting Insulin Market?

Major companies operating in the short-acting insulin market are focusing on innovative products such as insulin pods to provide continuous insulin infusion and adherence for individuals with diabetes. An insulin pod refers to a tubeless, wearable insulin delivery system that provides continuous insulin infusion for diabetes management. For instance, in April 2023, Insulet Corporation, a US-based medical device company, announced U.S. Food and Drug Administration (FDA) clearance for Omnipod GO, a groundbreaking basal-only insulin pod designed for adults with type 2 diabetes. This tubeless, wearable device offers continuous insulin delivery without the need for a separate controller. Omnipod GO simplifies diabetes management by eliminating daily injections and providing pre-programmed insulin rates. With its user-friendly design and pharmacy accessibility, it enhances convenience for both patients and healthcare providers. This launch reinforces Insulet’s commitment to improving diabetes care through innovative technology.

Which Companies Hold A Competitive Edge In The 551 Market?

Major companies operating in the short-acting insulin market are Sanofi S.A., Eli Lilly and Company, Novo Nordisk A/S, Baxter International Inc., Eisai Co. Ltd., Sumitomo Pharma Co. Ltd., Biocon Limited, Kissei Pharmaceutical Co. Ltd., Lupin Limited, Wockhardt Ltd., Lannett Co. Inc., MannKind Corporation, Sihuan Pharmaceutical Holdings Group Ltd., Julphar(Gulf Pharmaceutical Industries), Geropharm LLC, Bioton S.A., hec pharm co. ltd, ADOCIA SAS, Gan & Lee Pharmaceuticals Co. Ltd., Adocia S.A.S.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/short-acting-insulin-global-market-report

Which Region Dominates The Short-Acting Insulin Market Today?

North America was the largest region in the short-acting insulin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the short-acting insulin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21287&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model